Taking your project from bench to clinical studies

OUR SERVICES
 

GMP facilities for injectable and freeze-dried biological products

OUR SERVICES
 

Manufacture of small customized clinical batches

KNOW MORE
 

Biosafety level 3 (BSL-3) facility under GMP

MORE INFORMATION
 

Our own project to develop a vaccine against tuberculosis

RUTI® Project
1
1

Archivel Farma is a biotech company focused on innovative immunotherapeutic products.

Archivel Farma is specialized in the development of injectable and freeze-dried products.

Manufacturing

Process Development & Tech Transfer Scale-up & GMPs manufacturing

Facilities

Biosafety level 3 (BSL-3)
Class A/B cleanroom

Analytical QC & RD

Development, validation and testing analytical methods

Qualified Team

Personal trained
CXPs and biosafety standards

News

General
24/03/2023

World TB Day

Today is #WorldTBDay, a day to raise awareness about the devastating impact of #tuberculosis – one of the world's oldest and deadliest diseases. #YesWeCanEndTB. #Archivelfarma is aligned with WHO goals…
Albert Canals
0
EU Project
15/02/2023

The STRITUVAD project has been completed

The STRITUVAD (In Silico TRIals for TUberculosis VAccine Development) project has been completed. It has been a great honour for Archivel to be part of this project co-funded by the…
Albert Canals
0
ArchivelGeneralResearch
30/09/2022

A new clinical trial, CONSTAN-ARG, will test the effectiveness of the #RUTI® vaccine

A new clinical trial, CONSTAN-ARG, will test the effectiveness of the #RUTI® vaccine to shorten treatment in #TB patients. #Archivel Farma has designed and set up a phase IIb clinical study called CONSTAN-ARG to…
Albert Canals
0